artemisinin-dye conjugate

Artemisinin-dye conjugate refers to a class of experimental compounds in which the antimalarial agent artemisinin is chemically linked (conjugated) to a dye molecule. The purpose of such conjugation is typically to enhance the selectivity, delivery, or imaging capabilities of artemisinin for specific biomedical applications, most notably cancer therapy. Artemisinin itself is a sesquiterpene lactone derived from Artemisia annua and is well known for its antimalarial and emerging anticancer properties. When conjugated with targeting moieties (such as transferrin or dyes), the resulting compound can exploit overexpressed receptors on cancer cells (e.g., transferrin receptor) or provide traceability via fluorescence or other imaging modalities. The mechanism of action for these conjugates generally involves receptor-mediated endocytosis into target cells, where intracellular iron catalyzes the activation of artemisinin's endoperoxide bridge, generating cytotoxic free radicals that induce cell death. This targeted approach aims to increase potency and selectivity against tumor cells while minimizing effects on normal tissues[1]. The dye component may also allow tracking or visualization in research settings. These compounds are under preclinical investigation primarily as potential anticancer agents; no approved pharmaceutical products based on this exact formulation currently exist.

Other names

artemisinin-dye conjugate